Regeneration of airway epithelial cells to study rare cell states in cystic fibrosis.


Journal

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
ISSN: 1873-5010
Titre abrégé: J Cyst Fibros
Pays: Netherlands
ID NLM: 101128966

Informations de publication

Date de publication:
03 2020
Historique:
received: 11 07 2019
revised: 13 09 2019
accepted: 16 09 2019
pubmed: 5 11 2019
medline: 13 10 2021
entrez: 5 11 2019
Statut: ppublish

Résumé

Pathological remodeling of the airway epithelium is commonly observed in cystic fibrosis (CF). Thus, tissue repair is critical to restore integrity and maintenance of the epithelial barrier function. Epithelial repair is a multi-step process initiated by progenitor cell migration into the injured area, proliferation, and re-differentiation into all of the cell types that contribute to the function of a normal airway epithelium. Recent technological advances applied to relevant animal and cell injury models have helped in understanding the complexity of progenitor cell differentiation. This short review will introduce the current knowledge of the mechanisms regulating airway epithelial cell (AEC) regeneration and repair, with a focus on the specification of two rare cell types/states: ionocytes and deuterosomal cells.

Identifiants

pubmed: 31680046
pii: S1569-1993(19)30894-X
doi: 10.1016/j.jcf.2019.09.010
pii:
doi:

Substances chimiques

Cystic Fibrosis Transmembrane Conductance Regulator 126880-72-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

S42-S46

Informations de copyright

Copyright © 2019 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest PB, AC, and MC do not have any conflicts of interest relevant to this publication. ABJ and LWP are employees of Novartis Institutes of BioMedical Research. ABJ is a stockholder in Novartis.

Auteurs

Pascal Barbry (P)

Université Côte d'Azur and CNRS, Sophia Antipolis, France.

Amélie Cavard (A)

Université Côte d'Azur and CNRS, Sophia Antipolis, France.

Marc Chanson (M)

Departments of Gynecology & Obstetric and Cell Physiology & Metabolism, Faculty of Medicine at the University of Geneva, Switzerland. Electronic address: marc.chanson@unige.ch.

Aron B Jaffe (AB)

Respiratory Diseases, Novartis Institutes for BioMedical Research, Cambridge, USA.

Lindsey W Plasschaert (LW)

Respiratory Diseases, Novartis Institutes for BioMedical Research, Cambridge, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH